Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Akttyva Therapeutics Logo
Akttyva Therapeutics Growth Score
43
CB Rank
176122
Heat Score
76
Akttyva Therapeutics develops targeted therapeutics that address cell barrier dysfunction across multiple indications.
Founded
obfuscation
PrivateGrant Mansfield, Massachusetts, United States1-10 akttyva.com/
Health Care
Therapeutics
Wellness
Overview

Akttyva Therapeutics
Total Funding
obfuscation
Growth Score
43
Heat Score
76

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score43
-12 pts
in past quarter
Heat Score 76
-11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Akttyva Therapeutics

CB Rank
176122
Akttyva Therapeutics develops targeted therapeutics that address cell barrier dysfunction across multiple indications.
Founded
obfuscation
PrivateGrant Mansfield, Massachusetts, United States1-10 akttyva.com/
Health Care
Therapeutics
Wellness

Funding Rounds

Grant
OBF
in
obfuscation
Non-equity Assistance
OBF
in
obfuscation

Details

Legal Name AKTTYVA THERAPEUTICS, INC.
Operating Status Active
Company Type For Profit
About the Company
Akttyva Therapeutics develops targeted therapeutics that address cell barrier dysfunction across multiple indications.
Phone Number +1-617-821-7095
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AIDE-360
An AI-assisted drug-discovery platform integrating biology, computational science, and experimental validation to develop targeted therapeutics.

Research & Development

Akttyva Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
1
obfuscation
National Science FoundationGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
1
obfuscation
National Science FoundationGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
National Science Foundation Logo
National Science Foundation
Yes
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Akttyva Therapeutics Logo
Grant - Akttyva Therapeutics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 2
News

News and Press

News•Dec 19, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 12, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 12, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

236
337.04%
 in past month

IT Spend

$266.6KThis year, Akttyva Therapeutics is projected to spend $266.6K on IT, according to Aberdeen.

Active Website Tech Count

3Akttyva Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Akttyva Therapeutics's headquarters? Akttyva Therapeutics is located in Mansfield, Massachusetts, United States.Who invested in Akttyva Therapeutics? Akttyva Therapeutics has 2 investors including National Science Foundation and  MassChallenge.When was the last funding round for Akttyva Therapeutics? Akttyva Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are Akttyva Therapeutics's competitors? Alternatives and possible competitors to Akttyva Therapeutics may include Insilico Medicine, Generate Biomedicines, and  Absci.How much funding has Akttyva Therapeutics raised to date? Akttyva Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|